Scientists Demonstrate Long-Sought Drug Candidate Can Halt Tumor Growth

Researchers from the Janda and Vogt labs have uncovered a "credit card-like" molecule that can disrupt a central step in the progression of such cancers as Burkitt’s lymphoma.

Scripps Research Institute Announces Interim Leadership

James Paulson, chair of TSRI’s Department of Cell and Molecular Biology, has been appointed acting president and CEO.

Chemists Uncover Powerful New Click Chemistry Reactivity

The research from the Sharpless lab opens the doorway to powerful new tools for making drugs, plastics and unprecedented smart materials.

Team Successfully Targets Common Mutation in Lou Gehrig’s Disease, Frontotemporal Dementia

Scientists led by Professor Matthew Disney of TSRI and Professor of Neuroscience Leonard Petrucelli of the Mayo Clinic have for the first time successfully designed a therapeutic strategy targeting a specific genetic mutation causing these diseases.

A Gene Linked to Disease Found to Play a Critical Role in Normal Memory Development

The new findings from the Puthanveettil lab could have implications for the development of future treatments for Huntington’s disease.

Team Awarded $4.4 Million to Investigate 10-Minute DNA Sequencing Technology

The Ghadiri lab is working on technology that holds promise to improve patient care, such as cancer treatment.